Latest News

On November 18, 2025, the Institute for Genomic Biology at the University of Illinois Urbana-Champaign announced a five-year partnership with Ginkgo Bioworks on a federally funded initiative to develop advanced phage-based therapies for oral health using Ginkgo's EncapS technology. This collaboration is expected to enhance Ginkgo's capabilities in microbiome research while highlighting the growing role of high-throughput screening platforms in healthcare innovation. We'll explore how this...

Wondering if Venture Global is a bargain or overpriced right now? You are not alone. Many investors are closely watching the stock's valuation story unfold. Venture Global’s share price has increased 4.9% over the last week, but it is still down 67.1% year-to-date. This suggests both potential for a rebound and shifting risk perceptions. These price movements follow headlines about Venture Global’s expansion plans in the LNG sector and regulatory discussions affecting US exporters. The mix...

Fulton Financial recently reported its third quarter results, showing a 5.3% year-over-year revenue increase and outpacing analyst estimates for both revenue and tangible book value per share. This positive performance highlights a contrast between Fulton Financial’s operational momentum and a more cautious investor response despite the company’s financial outperformance. To understand how outperformance relative to expectations may shift Fulton Financial’s outlook, we’ll review the broader...

In November 2025, Pediatrix Medical Group raised its full-year adjusted EBITDA guidance to US$270 million–US$290 million after fiscal Q3 results surpassed revenue expectations, despite a year-on-year decline linked to portfolio restructuring. This move signals that operational improvements are translating into stronger profitability, even amidst shifts to the company's business mix. We'll explore how Pediatrix Medical Group's upgraded profit outlook could influence its investment narrative...

Verizon Communications (VZ) shares have recently seen movement, catching the eye of investors looking for income and stability in the telecom sector. The company’s solid revenue base continues to anchor its long-term outlook. See our latest analysis for Verizon Communications. Verizon’s share price has inched up recently, putting in a 3.16% year-to-date price return. The stock’s one-year total shareholder return of 5.73% shows its ability to reward patient investors remains steady, even as...

Macy's (M) shares have seen some recent movement, piquing investor attention as the company navigates changes in the retail sector. The stock’s performance over the past month shows a clear uptick. This has encouraged fresh discussion around the brand’s valuation and outlook. See our latest analysis for Macy's. Over the last year, Macy's has delivered a total shareholder return of 35.5%, with momentum building lately as its 90-day share price return topped 51%. Recent gains indicate renewed...

Ever wonder if Amer Sports might be a hidden value play, or if the recent hype has already pushed it out of bargain territory? The stock has had some eye-catching moves lately, with an increase of 10.5% over the last week and a significant 61.4% rise over the past year. This signals both growth potential and shifting risk perceptions. Amer Sports has been making headlines for securing new distribution partnerships and increasing its presence in the premium sportswear market. These...

BSA Health System and Encompass Health recently opened the 50-bed Rehabilitation Hospital of Amarillo, providing comprehensive inpatient rehabilitation services for patients recovering from strokes, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions. This hospital features advanced rehabilitation technologies, a therapy courtyard, and individualized care plans, addressing significant needs in the Amarillo region's post-acute care landscape. We'll explore how...

Air Canada (TSX:AC) has seen its stock edge lower over the past week, reflecting a modest pullback after recent trading. For investors tracking the airline’s journey, short-term moves have sparked renewed interest in its longer-term outlook. See our latest analysis for Air Canada. While Air Canada’s latest share price of $17.84 reflects a modest weekly dip, this follows a longer stretch of underperformance, with a one-year total shareholder return down nearly 24%. The pullback signals some...

Wondering if Cheniere Energy is a hidden gem or priced to perfection? You are not alone, and digging into the numbers reveals some surprising insights. The stock has been on a bit of a roller coaster, delivering a flat 0.2% over the past week, down 3.0% for the month, and slipping 3.7% so far this year. It is still holding an impressive 276.0% gain over the last five years. Recent headlines have centered on the shifting global LNG market and Cheniere's ongoing efforts to secure long-term...

Medtronic recently reported second quarter fiscal 2026 results, posting revenues of US$8.96 billion and net income of US$1.37 billion, both up from the prior year, and raised its full-year guidance following strong growth in Cardiovascular and Cardiac Ablation Solutions along with several key U.S. FDA approvals. This performance was underpinned by very large growth in the Pulsed Field Ablation business and expanded product approvals, highlighting Medtronic's focus on innovation and...

Earlier this month, Scott+Scott Attorneys at Law LLP filed a securities class action lawsuit against Stride, Inc. and certain executives, alleging they misled investors about enrollment figures, cost-cutting practices, and regulatory compliance between October 2024 and October 2025. This lawsuit introduces fresh concerns about Stride's governance and transparency during a period of reported business expansion and strong market expectations. We'll examine how allegations around misleading...

Qfin Holdings announced its unaudited financial results for the third quarter ended September 30, 2025, reporting revenue of CNY 5.21 billion and net income of CNY 1.44 billion, with updated earnings guidance for the rest of the year. An interesting insight from the disclosure is that despite resilient platform activity and a significant share repurchase plan, quarterly net income declined compared to the prior year, highlighting ongoing macroeconomic and regulatory headwinds. Next, we'll...

FMC Corporation recently faced a series of negative developments, including multiple analyst downgrades, a dividend cut, weaker-than-expected third-quarter sales, and the departure of its long-serving president Ronaldo Pereira, all aimed at addressing high debt and challenging market conditions. Board member John Mitchell Raines significantly increased his investment in FMC by purchasing 7,000 shares after the stock experienced steep declines and disappointing results, signaling ongoing...

Duke Energy reported third quarter 2025 earnings on November 7, revealing sales of US$8.54 billion and net income of US$1.42 billion, both higher than the same period last year. Investors are closely watching Duke Energy's signal of a major five-year capital plan update, which may highlight significant investment and future growth opportunities. We'll explore how Duke Energy's strong third quarter financial results and the upcoming capital plan announcement could influence its long-term...

Humana (HUM) has faced a rough stretch lately, with shares declining nearly 15% over the past month. Investors are watching closely as the company navigates changing healthcare trends and adjusts its outlook in a challenging market. See our latest analysis for Humana. Humana’s rough patch is not just a blip, with momentum fading as shown by a 1-year total shareholder return of -14.5% and a sharper three-year total shareholder return decline of over 54%. While shares have fallen some more...

Clean Harbors (CLH) has caught the attention of investors following new coverage and ratings updates from several major investment firms, as well as the company’s latest report showing that both revenue and net profit climbed last quarter. See our latest analysis for Clean Harbors. Following a wave of ratings updates and robust quarterly results, Clean Harbors’ momentum has been mixed. After a sharp short-term drop, the latest 1-day share price return of 3.74% hints that investor confidence...

Cameco (TSX:CCO) shares have seen a mixed stretch lately, catching the attention of investors tracking the uranium sector. After a strong run this year, recent weeks have brought some profit-taking and renewed questions about valuations. See our latest analysis for Cameco. Cameco’s share price has experienced plenty of action this year, with strong momentum pushing shares up over 55% year-to-date before recent gains cooled, leading to some pullback in the past week. Even so, long-term...

Aramark (ARMK) stock has been catching some interest as investors look for value after a challenging stretch. Shares have slid roughly 5% over the past month, which has prompted conversations about where the company could head next. See our latest analysis for Aramark. After a tough quarter, Aramark’s share price has been under pressure, falling 5.3% over the past month as investors reassess the company’s outlook amid shifting market sentiment. Even so, Aramark still boasts a solid three-year...

Roche recently announced positive Phase 3 results for its breast cancer drug giredestrant, a therapy in the same class as Olema Pharmaceuticals’ lead candidate, palazestrant. This development has been widely viewed by investors as strong external validation of Olema’s drug approach in estrogen receptor-positive, HER2-negative early-stage breast cancer. We’ll explore how Roche’s clinical trial success in a similar drug class shapes the outlook for Olema’s investment narrative. This technology...

Shearwater Group plc's ( LON:SWG ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a strong buy right...

Renishaw (LON:RSW) has had a great run on the share market with its stock up by a significant 12% over the last three...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

While China Literature Limited ( HKG:772 ) shareholders are probably generally happy, the stock hasn't had particularly...